Researchers have made a groundbreaking discovery that could explain why nonsteroidal anti-inflammatory drugs (NSAIDs) can worsen gastrointestinal infections caused by Clostridioides difficile, commonly known as C. diff.
Scientists have demonstrated for the first time that treatments with engineered bacteria can significantly improve the quality of life in patients with C. difficile infections
Research from Newcastle University in England gives a closer look at how a diarrhea-causing superbug opposes immune cells and antibiotics.
Fecal transplants could be the answer to treating one of the most common life-threatening intestinal infections.
Johns Hopkins research suggests that C. diff infections may contribute to the rise of colorectal cases in young Americans.
If successful, Dr. Moonah’s work would be the first to deliver a drug treatment using an amoeba or another protozoan.
The transplantation of healthy feces into patients with C. difficile promotes the growth of healthy gut bacteria and eases the symptoms of infections.